| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.013 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0012 | 1 |